WHO WE ARE
Your mGC Founders
Our Founders are certified genetic counselors with more than 30 years of clinical experience and leadership in genetic counseling and testing. From deep in the trenches of clinical care, they saw the need to provide consumers and clinicians with a progressive, digital method of staying up-to-date on their genetic test results.
Ellen Matloff, MS, CGC is the President and CEO of My Gene Counsel. Ellen is the founder and former director of the Cancer Genetic Counseling Program at Yale School of Medicine.
Ellen has authored more than 50 scientific publications in the field, is an established educator, lecturer and media spokesperson and has received national awards for her ongoing patient advocacy efforts. She is an outspoken patient advocate in many areas, most notably as a plantiff in the 2013 BRCA gene patent case that went before the Supreme Court in 2013. This decision has led to drastically lower prices of genetic testing, making it possible for more patients to afford this technology.
As genetic testing became more common and also more complex, she served as the senior author on several publications documenting national errors in the misinterpretation of genetic test results. From these experiences, Ellen created My Gene Counsel and its associated digital tools that can be used in parallel with genetic testing to help ensure that results are used accurately and effectively.
Danielle Bonadies, MS, CGC is the Director of Genetics at My Gene Counsel. She is responsible for the development of our Living Lab Report content that populates the My Gene Counsel portal.
Before joining My Gene Counsel, Danielle served as the Assistant Director of the Cancer Genetic Counseling Program at Yale School of Medicine. She practiced as a clinical genetic counselor for over a decade, designed and ran several interactive, on-line patient education and communication sites, and was involved in the cancer genetics education of thousands of patients, clinicians and students.
Danielle has co-authored multiple book chapters and articles in genetic counseling and testing. She was involved in several seminal papers that document the high rate of result misinterpretation amongst clinicians ordering genetic testing. In addition, her publications include work that helps understand the viewpoint of genetic counselors and physicians on a wide range of complex decisions associated with cancer genetic testing. Other publications focus on the informational needs of individuals with hereditary predispositions during decision making periods. These experiences helped set the stage for her involvement in My Gene Counsel and the development of a digital, scalable genetic counseling solution to aide the rapidly complex arena of genetic testing.
Danielle’s strong clinical, research and advocacy background illustrate her ongoing commitment to the field of hereditary cancers. She brings this dedication and leadership to the My Gene Counsel team.
Meagan Farmer, MS, CGC, MBA is the Genetic Counseling Business Manager of My Gene Counsel. Meagan connected with Ellen and Danielle when she completed the Yale Cancer Genetic Counseling fellowship in 2010. She was a consultant for My Gene Counsel before coming on board full time in 2018.
Meagan is the former director of the Cancer Genetic Counseling Program at the University of Alabama at Birmingham. She remains affiliated with the program and participates in patient care, teaching, and research activities. She co-authored a book, book chapters, and several articles on genetic counseling and genetic testing. She is also on the board of the Norma Livingston Ovarian Cancer Foundation.
Meagan has a special interest in increasing access to genetic information through innovative service delivery models and digital solutions. She expanded the telemedicine program at UAB and is active in telehealth and precision medicine initiatives at UAB as well as on regional and national levels. Meagan recognized that both business acumen and technology are crucial in making genetic counseling scalable in the genomic era. To better prepare for this, she completed her MBA with concentrations in healthcare and technology.
Chief Technology Officer (CTO)
Shyam Deval serves as the Chief Technology Officer (CTO) of My Gene Counsel. Shyam has been working in the healthcare technology space for eleven years, with extensive experience in the articulation, design, creation, launch, and management of mobile and web health applications. Shyam has past experiences in a Technology leadership role with both healthcare start-ups and larger organizations in Healthcare delivery and Biotech, Technology Products and Education domains. Shyam has been a programmer, data architect, project and program manager, product strategist, and educator in his over 20-year career.
Shyam spent four years as the President at Boston Technology Corporation (BTC) – one of the fastest growing healthcare technology companies in Boston. Shyam managed all of BTC’s healthcare technology offerings and clients, which included multiple Healthcare start-ups, large provider organizations, Universities and FDA. As part of his work with BTC, Shyam participated as the technical liaison in several successful initiatives focused on the use of technology to improve patient collaboration, research and care delivery.
Vice President of Marketing
Jill Mastrianni is the Vice President of Marketing for My Gene Counsel. She is a seasoned marketing and business development executive with 20+ years of achievement developing and directing strategic marketing initiatives in highly competitive industries including healthcare, legal, non-profit, and education sectors.
Jill is responsible for overseeing My Gene Counsel’s brand marketing, internet marketing, and sales support functions. She is a key contributor toward all product definition and specification efforts with an eye toward optimizing customer adoption, activity and satisfaction. Working as a key member of the leadership team she will collaborate to develop and foster new strategic relationships which help grow revenue streams.
Jill brings a unique broad business-mind perspective of developing strategic plans to establish and decipher best tactics and platforms for customer and investor engagement. Using her past experience creating and implementing scalable business solutions she will develop a healthy growth strategy that continues to expand and enhance My Gene Counsel's customer base. Prior to joining the team Jill held several high-profile positions, more recently including Chief Marketing Officer of Connecticut’s largest law firm.
Kira Dineen is the Communication Lead of My Gene Counsel. In this role she develops strategies to establish My Gene Counsel’s thought leadership platform and fosters engagement around consumer advocacy and education through online media. Kira brings 5 years of online media experience in the fields of digital marketing, social media, blogging and podcasting/radio.
She is passionate about advocating for the rare disease community and has worked collaboratively with the National Organization for Rare Disorders to provide education and raise awareness.
Kira received her Bachelor's of Science degree in Diagnostic Genetic Sciences with a concentration in Cytogenetics at the University of Connecticut. She hosts and produces a podcast/radio show, DNA Today, which educates the public on genetics and has been nominated in the 2015 and 2016 Podcast Awards.
Vincent T. DeVita, Jr., MD,FACP, FASCO, FAACR
Advisor and Board Member
Vincent T. DeVita, Jr., MD, FACP, FASCO, FAACR, Amy and Joseph Perella Professor of Medicine and Professor of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT. While Dr. DeVita was at the National Cancer Institute (NCI), he developed combination chemotherapy programs that ultimately led to an effective regimen (MOPP) of curative chemotherapy of Hodgkin's disease and diffuse large B-cell lymphomas. In 1972, DeVita received the Albert and Mary Lasker Medical Research Award for his contribution to the cure of Hodgkin's disease. He was elected to the National Academy of Medicine in 1974. In 1980, he was appointed by the President of the United States as Director of the NCI and the National Cancer Program. In 1988, DeVita joined Memorial Sloan-Kettering Cancer Center as Physician-in-Chief. He served as Professor of Medicine at Cornell University School of Medicine until 1993. He served as the Director of Yale Cancer Center from 1993 to 2003. In 2002, he was elected to the European Academy of Sciences for his outstanding and lasting contribution to cancer research and medical education. DeVita held the position of President of the American Cancer Society in 2012-13. He is one of three editors of Cancer: Principles & Practice of Oncology, a comprehensive textbook in the field of cancer medicine and author of the lay book The Death of Cancer written with his daughter Elizabeth DeVita Raeburn, a science writer, published in 2015.
Gillian Hooker, PhD, ScM, LCGC
Gillian Hooker’s career has focused on implementation and outcomes of genetic counseling and testing, first as an academic and more recently in her position as the Vice President of Clinical Development for Concert Genetics. In her role at Concert, she provides clinical leadership and coordinates several internal and external collaborations to use test order data, insurance claims and genetic testing market data to inform policy development for hospitals, health plans and federal policy makers.
She has been actively involved in the National Society of Genetic Counselors, is a past chair of the NSGC Research SIG and Practice Guidelines Committees and joined their board of directors in 2018. She currently serves on the advisory committee of the Vanderbilt Genetic Counseling Training Program and as a thesis advisor to students in the University of Alabama Genetic Counseling Training Program. Gillian completed her PhD in Molecular Genetics at Yale University and her master’s degree in Genetic Counseling at the Johns Hopkins/NIH Genetic Counseling Training Program.
David Cohen, MBA
Advisor and Board Member
David Cohen, MBA is an advisor and Board member of My Gene Counsel. He is a highly experienced business executive, entrepreneur and investor who has served as Executive VP of Standard Oil of Connecticut, Inc. for the past 22 years. David has also founded a number of highly successful ventures, including: Standard Security Systems, ResCom Energy, Moneo Technology Solutions and Standard Oil Ventures. He sits on the boards of multiple companies, including several in the health care arena.